NCT02209181 - A Dental Pain Study to Test the Effectiveness of a New Pain Reliever Medicine | Biotech Hunter

Enrollment

269

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Pain

Interventions

DRUG

JNJ-10450232 / Not yet marketed

Subjects who meet the randomization criteria at baseline within 4.5 hours after dental surgery will be assigned to one of four treatment groups stratified by pharmacokinetic blood sampling schedule and by baseline pain intensity level.

DRUG

JNJ-10450232 / Not yet marketed

Subjects who meet the randomization criteria at baseline within 4.5 hours after dental surgery will be assigned to one of four treatment groups stratified by pharmacokinetic blood sampling schedule and by baseline pain intensity level.

DRUG

JNJ-10450232 / Not yet marketed

Subjects who meet the randomization criteria at baseline within 4.5 hours after dental surgery will be assigned to one of four treatment groups stratified by pharmacokinetic blood sampling schedule and by baseline pain intensity level.

DRUG

acetaminophen / Tylenol

Subjects who meet the randomization criteria at baseline within 4.5 hours after dental surgery will be assigned to one of four treatment groups stratified by pharmacokinetic blood sampling schedule and by baseline pain intensity level.

Trial Locations (1)

84124

Jean Brown Research, Salt Lake City